baber/WOPTO huggingface dataset:
Patent NZ-218673-A (NZ)
Title: Crosslinkable polymeric compositions comprising an elastomeric polymer and a benzocyclobutene derivative
Inventor: PUI KWAN WONG
IPC: C08K5/01
Filed: 1986-12-17
Abstract: Polymeric compositions which may be readily cross-linked at temperatures above about 200  DEG C comprise an elastomeric polymer possessing olefinic unsaturation and an effective amount of a benzocyclobutene derivative of the general formula <CHEM>  where "X" is selected from the group consisting of <CHEM>  and -(R-)- where "R" is an alkylene group of 1 to 10 carbon atoms. Cured compositions are also claimed.
Patent NZ-219482-A (NZ)
Title: Fuel compositions containing succinic acid and polyamide derivatives
Inventor: VOS B
IPC: C10L1/14
Filed: 1987-03-03
Abstract: Fuel composition comprising a major amount of base fuel and a minor amount of an additive a) being a polyhydric alcohol ester of a succinic acid derivative having as substituent on at least one of its  alpha -carbon atoms an unsubstituted or substituted aliphatic hydrocarbon group having from 20 to 500 carbon atoms or of a succinic acid derivative having on one of its  alpha -carbon atoms an unsubstituted or substituted aliphatic hydrocarbon group having from 20 to 500 carbon atoms which is connected to the other  alpha -carbon atom by means of a hydrocarbon moiety having from 1 to 6 carbon atoms forming a ring structure, and further a minor amount of an additive b) being an aliphatic polyamine containing at least one hydrocarbon chain having a number average molecular weight in the range from 500 to 10,000 attached to nitrogen and/or carbon atoms of the alkylene radicals connecting the amino nitrogen atoms.
Patent NZ-223022-A (NZ)
Title: Dibenzo(be)oxepineacetic acid derivatives and pharmaceutical compositions
Inventor: SYNTHELABO
IPC: C07D313/12
Filed: 1987-12-21
Abstract: A compound, in the form of a pure optical isomer or a racemate, which is a dibenzo[_b]oxepinacetic acid of the general formula (I) <IMAGE>  (I)   in which R1, R2 and R3, which may be the same or different, each represent hydrogen or methyl, XX represents a carbon-carbon bond or two hydrogen atoms, and YY represents a carbon-carbon bond or two hydrogen atoms, or a pharmaceutically acceptable salt thereof has useful therapeutic properties, especially as an anti-inflammatory.
Patent NZ-230999-A (NZ)
Title: Production of hydrolysed proteins by acid then alkali treatment
Inventor: CORNET PAUL-EMILE
IPC: A23J3/32
Filed: 1989-10-12
Abstract: A process for the production of a hydrolysed protein which comprises hydrolysing a plant or animal protein with hydrochloric acid to give a slurry and then, before or after filtering off the residual unhydrolysed material, treating with alkali to a pH of from 8 to 14 and holding for a period of time to reduce the amount of undesirable chlorinated compounds and readjusting to a pH of from 4 to 7 to give a liquid hydrolysed protein filtrate.
Patent NZ-233525-A (NZ)
Title: Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers and pharmaceutical compositions
Inventor: STOKBROEKX RAYMOND ANTOINE
IPC: C07D413/12
Filed: 1990-05-01
Abstract: Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers of formula <CHEM> X is N or CH; Alk is C1-4alkanediyl; R<1> and R<2> are hydrogen, C1-4alkyl or halo; R<3> is hydrogen, halo, cyano, C1-4alkyloxy, aryl or -COOR<4>, with R<4> being hydrogen, C1-4alkyl, arylC1-4alkyl, C3-6cycloalkylC1-4alkyl, C3-5alkenyl, C3-5alkynyl or C1-4alkyloxyC1-4alkyl; or R<3> is a radicai of formula <CHEM> the addition salts and stereochemically isomeric forms thereof, said compounds having antirhinoviral activity. Pharmaceutical compositions containing these compounds as active ingredient, and a method of preparing said compounds and pharmaceutical compositions.
Patent NZ-235577-A (NZ)
Title: 4'-vinylhalo-inosine/guanosine derivatives and pharmaceutical compositions thereof
Inventor: JARVI ESA TERO
IPC: A61K31/7064
Filed: 1990-10-05
Abstract: This invention relates to novel compounds of the formula <CHEM>  wherein X1 and X2 are each independently hydrogen or halogen with the proviso that at least one of X1 and X2 is a halogen atom, A1 and A2 are each independently hydrogen, halogen or hydroxy with the provisos that where A1 is hydroxy, A2 is hydrogen, and where A2 is hydroxy, A1 is hydrogen, Y1 is nitrogen, a CH group, a CCl group, a CBr group or a CNH2 group,  Y2 is nitrogen or a CH group, and  Z is hydrogen, halogen, or NH2, which are useful as antiprotozoal agents.
Patent NZ-237781-A (NZ)
Title: Endless belt for shrinking sheet material: inner and outer layers have different moduli of elasticity
Inventor: RICH GERARD
IPC: D06C21/00
Filed: 1991-04-10
Abstract: This endless conveyor belt (5) is characterised in that it is produced from two materials, one of which constituting the conveyor-belt thickness fraction (10) on the sheet-type material side is more flexible than the other material constituting the other thickness fraction or remaining thickness (11) of the conveyor belt, so as to confer on the latter differential elasticity properties adapted to the material to be shrunk. The endless conveyor belt according to the invention is intended, for example, to equip the shrinking unit of a machine for shrinking fabrics. <IMAGE>
Patent NZ-239671-A (NZ)
Title: Process for removing off-flavour notes from a secondary coffee extract with an alkaline molecular sieve
Inventor: WEISEMANN CLAUS
IPC: A23L5/20
Filed: 1991-09-05
Abstract: In a process for deacidifying and improving the flavor of socalled secondary extracts obtained in the production of instant coffees, the secondary extracts are pumped over alkaline molecular sieves and are therewith completely or partially liberated from acids and flavor-impeding organic compounds.
Patent NZ-244962-A (NZ)
Title: Biphenylylquinuclidine derivatives and pharmaceutical compositions
Inventor: BROWN GEORGE ROBERT
IPC: A61P31/04
Filed: 1992-10-30
Abstract: PCT No. PCT/GB92/01968 Sec. 371 Date Jun. 30, 1993 Sec. 102(e) Date Jun. 30, 1993 PCT Filed Oct. 27, 1992Biphenylylquinuclidine compounds of the formula I:    <IMAGE>  I  and pharmaceutically-acceptable salts thereof; wherein R1 is hydrogen or hydroxy; R2 is hydrogen; or R1 and R2 are joined together so that CR1-CR2 is a double bond; and one or both ring A and ring B may be optionally unsubstituted or independently substituted by one or more substituents selected from halogeno, hydroxy, amino, nitro, cyano, carboxy, carbamoyl, (1-6C)alkyl, (1-6C)alkoxy, (1-6C)alkylamino, di-[(1-6C)alkyl]amino, N-[(1-6C)alkyl]carbamoyl, N,N-di-[(1-6C)alkyl]carbamoyl, (1-6C)alkoxycarbonyl, (1-6C)alkylthio, (1-6C)alkylsulphinyl, (1-6C)alkylsulphonyl and halogeno-(1-6C)alkyl; are inhibitors of squalene synthase and are hence useful in treating diseases or medical conditions such as hypercholesterolemia, atherosclerosis and fungal diseases. Methods of using these compounds to treat such conditions, novel compounds, processes for making these compounds and pharmaceutical compositions containing them are claimed.
Patent NZ-255980-A (NZ)
Title: Coal flotation process; comprises dispersing a surfactant through a slurry of coal and gangue, conditioning the slurry, dispersing oil throughout the slurry, conditioning again and floating coal on surface
Inventor: MCKENNY COLIN JOHN
IPC: B03B1/04
Filed: 1993-09-28
Abstract: A process for the flotation of particles of lignitic coal, subbituminous coal or oxidized bituminous coal contained within a slurry of coal and gangue, comprising the steps of dispersing a surfactant throughout the slurry, first conditioning the slurry such that the surfaces of the particles of coal are selectively coated by the surfactant to produce activated particles of coal, dispersing an oil throughout the slurry, second conditioning the slurry such that the surfaces of the activated particles of coal are selectively coated by the oil to produce oiled particles of coal, and floating the oiled particles of coal on the surface of the slurry for separation from the slurry and gangue.
Patent NZ-266746-A (NZ)
Title: Degumming a fatty substance; fats so obtained
Inventor: JAMIL SAID
IPC: C11B3/16
Filed: 1994-06-16
Abstract: PCT No. PCT/BE94/00041 Sec. 371 Date Feb. 26, 1996 Sec. 102(e) Date Feb. 26, 1996 PCT Filed Jun. 16, 1994Process for degumming a fatty substance such as a crude or delecithinated, animal or vegetable oil or fat, including bringing this fatty substance into contact with an aqueous solution of a complexing agent and of a detergent and/or emulsifier making it possible to hydrate the phospholipids present in the latter, and fatty substance thus obtained.
Patent NZ-267045-A (NZ)
Title: Multiple capillary optical analyser
Inventor: DOVICHI NORMAN J
IPC: G01N27/447
Filed: 1994-06-02
Abstract: A multiple capillary analyzer allows detection of light from multiple capillaries with a reduced number of interfaces through which light must pass in detecting light emitted from a sample being analyzed, using a modified sheath flow cuvette. A linear or rectangular array of capillaries is introduced into a rectangular flow chamber. Sheath fluid draws individual sample streams through the cuvette. The capillaries are closely and evenly spaced and held by a transparent retainer in a fixed position in relation to an optical detection system. Collimated sample excitation radiation is applied simultaneously across the ends of the capillaries in the retainer. Light emitted from the excited sample is detected by the optical detection system. The retainer is provided by a transparent chamber having inward slanting end walls. The capillaries are wedged into the chamber. One sideways dimension of the chamber is equal to the diameter of the capillaries and one end to end dimension varies from, at the top of the chamber, slightly greater than the sum of the diameters of the capillaries to, at the bottom of the chamber, slightly smaller than the sum of the diameters of the capillaries. The optical system utilizes optic fibres to deliver light to individual photodetectors, one for each capillary tube. A filter or wavelength division demultiplexer may be used for isolating fluorescence at particular bands.
Patent NZ-274423-A (NZ)
Title: Composition comprising ibuprofen and terfenadine
Inventor: ERTEL KEITH DAVID
IPC: A61K31/445
Filed: 1994-09-28
Abstract: PCT No. PCT/US94/10972 Sec. 371 Date Jul. 3, 1996 Sec. 102(e) Date Jul. 3, 1996 PCT Filed Sep. 28, 1994 PCT Pub. No. WO95/11677 PCT Pub. Date May 4, 1995The present invention is directed to a chemically stable pharmaceutical composition containing ibuprofen in combination with terfenadine, wherein the oxidation of terfenadine to terfenadone is prevented by the presence in the composition of an  alpha -hydroxy carboxylic acid.
Patent NZ-305651-A (NZ)
Title: Airless paint sprayer outlet check valve having two springs of high and low spring rates
Inventor: CONASTER ROGER
IPC: B05B9/04
Filed: 1996-03-25
Abstract: An airless paint sprayer includes an outlet check valve assembly having a dual spring configuration which allows for increased fluid flow through the valve without diminishing response time of the valve or the priming operations of the system. One of the springs is not engaged when the valve is closed and the other spring has a much lower spring rate and biases the valve toward a closed configuration when the valve is open, closed, and all positions therebetween. The dual spring configuration accommodates highly viscous fluids or paints with maximum fluid flow and no detrimental impact on the priming operations of the sprayer.
Patent NZ-311595-A (NZ)
Title: Roll forming structural steel profiles with galvanised coating
Inventor: CROSSINGHAM BRIAN ROY
IPC: C23C2/06
Filed: 1996-07-09
Abstract: PCT No. PCT/AU96/00431 Sec. 371 Date Jan. 9, 1998 Sec. 102(e) Date Jan. 9, 1998 PCT Filed Jul. 9, 1996 PCT Pub. No. WO97/03218 PCT Pub. Date Jan. 30, 1997Structural steel profiles such as channels, having a material thickness greater than 2 mm, are roll-formed to a preform profile with corners partial bent, in-line galvanized, and then further roll-formed to final shape. The preform profile has upwardly facing convex surfaces allowing rapid shedding of excess galvanising material. By preforming corners before galvanising, surface elongation in the galvanising layer is minimized and cracking eliminated. This is enhances by constant length bending of corners over preform and final roll-forming operations.
Patent NZ-504584-A (NZ)
Title: An apparatus and a method for measuring radiation
Inventor: WARME LENNART
IPC: G01T1/178
Filed: 1998-11-19
Abstract: An apparatus and method for measuring low energy sample radiation emanating from a sample containing a radiant matter, particularly for measuring â-radiation emanating from a 14C labeled compound, comprising first and second radiation detectors for measuring the radiation and background radiation, the first and second detectors being positioned substantially parallel with their respective active surfaces facing each other in an aligned position, at a distance allowing for temporary insertion of a sample device of planar configuration in a measurement cavity between the detectors.  The external shielding means enclosing the radiation detectors, the shielding means enclosing the radiation detectors, the shielding means reducing background radiation present in the measurement cavity, the shielding means being provided with an opening for receiving the sample device.  Electronic processing means for handling decay pulses received from the radiation detectors, calculating from the pulses the radiation originating from the sample and evaluating the result of the calculation; and means for recording and/or displaying the results of the evaluation.
Patent NZ-507464-A (NZ)
Title: Benzenesulfonamide and pyridinesulfonamide containing indole compounds for as pharmaceuticals having anti- angiogenic and/or anti-cancer properties
Inventor: OKABE TADASHI
IPC: A61P19/02
Filed: 2000-02-24
Abstract: An indole compound of formula (I); where: R1 is H, halogen or cyano; R2 and R3 are independently H, alkyl or halogen; R4 is H or alkyl; Ring A is cyanophenyl, aminosulfonylphenyl, aminopyridyl, aminopyrimidyl, halopyridyl or cyanothiophenyl; Provided that the following are excluded: i) The compound where R1=R2=R3=H. ii) The compound where R2=R3=H. iii) The compound where ring A is aminosulfonyl and R1=R2=halogen. iv) The compound where ring A is cyanophenyl, 2-amino-5- pyridyl or 2-halo-5-pyridyl, R1 is cyano or halogen and R2=R3=H. Also described is an antiangiogenic agent which comprises the compound of formula (I). The compounds of formula (I) are useful as preventative or therapeutic agents for diseases against which an antiangiogenic agent is effective for prevention or therapy thereof.
Patent NZ-510114-A (NZ)
Title: Hose reel mount consisting of reel support being rotatable about vertical support
Inventor: PALLESEN RONALD ASHLEY
IPC: B65H75/34
Filed: 2001-02-21
Abstract: The support consists of cradle (c) of angle iron members F fixed to shaft (d) supported in tube e. In use hose reel (a) can be rotated at least 360o.
Patent NZ-515830-A (NZ)
Title: A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
Inventor: OLSHENITSKY MARK
IPC: A23K1/00
Filed: 2000-06-01
Abstract: A viable, non-pathogenic probiotic microorganism Escherichia coli strain BU-230-98 ATCC Deposit No.202226 (DSM 12799), and its combined use in a probiotic composition with a volatile fraction of a plant extract that has been prepared by steam distillation (under reduced pressure and at a temperature less than 38C), said composition having therapeutic activity in the gastrointestinal tract, for example treating infectious diarrhoea.
Patent NZ-516403-A (NZ)
Title: Stabilised N-chlorosulfamate compositions having enhanced antimicrobial efficacy
Inventor: REES WAYNE M
IPC: C02F1/50
Filed: 2000-06-28
Abstract: The   antimicrobial  efficacy  of   N-chlorosulfamate solutions, namely buffered aqueous combinations of  HClNSO3- (mono-N-chlorosulfamate)      and       Cl2NSO3       (di-N- chlorosulfamate),   herein  referred   to   as   "stabilized hypochlorite", can be markedly enhanced by the  addition  of certain  organic dopants. The dopants themselves are  select hypochlorite stabilizing agents, which are known to  readily form  stable  organochloramides  when  reacted  with  "free" hypochlorite    (HOCl    or   NaOCl).    Highly    effective antimicrobial   enhancing   dopants   include    5,5-dialkyl hydantoins, arylsulfonamides, and succinimides. Examples  of these   include  5,5-dimethylhydantoin,  benzenesulfonamide, and  succinimide.  Other,  less  effective  dopants  include glycolurils.  Generally, the dopant is present  in  a  minor mole  fraction, relative to the molar amount  of  stabilized hypochlorite present in the enhanced antimicrobial solution
Patent NZ-520781-A (NZ)
Title: Treatment and diagnosis of sleep disordered breathing
Inventor: HEDNER JAN
IPC: A61K9/70
Filed: 2001-02-14
Abstract: Use of topiramate for the manufacture of a medicament for the treatment of sleep disordered breathing including sleep apnea or for the manufacture of a diagnostic device or composition for the diagnosis of sleep disordered breathing. Also disclosed is a protective patch comprising topiramate in an amount therapeutically effective in the treatment of sleep disordered breathing including sleep apnea and a pharmaceutically acceptable carrier for transdermal or transmucosal administration.
Patent NZ-530332-A (NZ)
Title: Hydrogel beads or capsules as artificial media for insects oviposition and rearing of endoparasitoids
Inventor: HANCE THIRRY
IPC: A01N63/14
Filed: 2002-06-21
Abstract: The use of a biopolymer beads or capsule for in vitro rearing of endoparasitoids, characterized in that the biopolymer bead or capsule is used for oviposition and continuous rearing of an endoparasitoid from the egg through to the adult emergence of the endoparasitoid where in the capsule may be composed of alginate, carrageenan and/or chitosan; a method for in vitro rearing endoparasitoids comprising the use of the biopolymer bead or capsule; and method for preparing the biopolymer bead or capsule.
Patent NZ-532688-A (NZ)
Title: A device for mounting goods on a display unit such that goods may be removed from the unit whilst remaining secured to the unit
Inventor: MINNICI FRANK
IPC: A47F7/00
Filed: 2002-10-28
Abstract: A device for securely mounting goods on a display unit, the display unit having at least one mounting bar thereon, includes: a) A housing (1) having: i) An aperture (3) adapted to receive the mounting bar (9) in use; ii) A first mounting (4); and, iii) A second mounting (5); and, b) A first fixing device (20), the first fixing device is coupled to the goods in use and being attachable to the first mounting to allow the goods to be removably mounted to the housing ; and, c) A second fixing device (30), the second fixing device is coupled to the goods and the second mounting in use, to thereby secure the goods to the display unit, such that the goods may be removed from the housing whilst remaining secured to the housing.
Patent NZ-535833-A (NZ)
Title: Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use
Inventor: DEFOSSA ELISABETH
IPC: C07C/
Filed: 2003-03-28
Abstract: Disclosed is a compound of formula I wherein: R7, R8, R9 and R10 are independently of each other H, F, Cl, Br, OH, NO2, CN, O-alkyl, O-alkenyl, O-alkynyl, O-SO2-alkyl, alkyl, alkenyl, alkynyl where alkyl, alkenyl and alkynyl can be substituted by F, Cl or Br; R1 and R2 are independently of each other, H, alkyl where the alkyl can be substituted as defined. R3, R4, R5 and R6 are indepently, H, F, Cl, Br, NO2, CN, O-R11, N(R12)(R13), alkyl, alkenyl, alkynyl, cycloalkyl, or cycloalkyl-alkylene, where alkyl, cyclolalkyl and alkynyl can be substituted by F, Cl, Br, OR11 or N(R16)(R17) and R11, R12, R13, R16 and R17 are as defined. The compound is disclosed for use as a pharmaceutical having the effect of lowering blood sugar and treating type 2 diabetes.
Patent NZ-536558-A (NZ)
Title: Bis-aromatic alkanols
Inventor: FAN YING
IPC: A61P31/12
Filed: 2003-05-26
Abstract: Disclosed is a compound of formula I wherein: Y is ?CH2CH2-, -CH2CH(OH)-, -CH(OH)CH2-, -CH2C(O)-, -CH=CH- or 1,2-cyclopropylene; X is arylene of C5-6heteroarylene optionally substituted by one to three substituents selected from halogen, nitro, C1-10alkyl and halogen-substituted C1-6alkyl; R1 is aryl, aryl-C2-4alkenyl, heteroaryl, or heteroaryl-C2-4alkenyl each substituted as defined; R2 is hydrogen, halogen, C1-4 alkyl optionally substituted with one or more halogens, C2-6 alkenyl, C2-6alkynyl, cycloalkyl optionally substituted by halogen, aryl optionally substituted with hydroxyl, C1-4alkyl optionally substituted on the terminal C atom by OH or a residue of formula (h) with substituents as defined; R3 and R4 are independently, H, or C1-4alkyl optionally substituted by halogen or acyl; and R5 is H, -OH, -Oacyl, -NHacyl, or a residue of formula (h) as defined. With the proviso that at least R2 comprises a terminal OH or a residue of formula (h) or R5 is OH or a residue of formula (h). Compounds of the type disclosed are useful either alone or in combination with an immunosuppressive, immunomodulating, anti-inflammatory or chemotherapeutic agent for treating disorders or diseases mediated by lymphocytes, preventing or treating acute or chronic transplant rejection or T-cell mediated inflammatory or autoimmune diseases, for inhibiting or controlling deregulated angiogenesis, or for preventing or treating diseases mediated by neo-angiogenesis.
Patent NZ-537458-A (NZ)
Title: Means and methods for treatment evaluation
Inventor: VAN DER KUYL ANTOINETTE CORNEL
IPC: C12Q1/68
Filed: 2002-01-23
Abstract: Disclosed is a method for determining whether a treatment is effective in changing a status of a certain set of target cells in an individual comprising determining whether a sample, other than a hemopoietic cell, from said individual comprises an expression product of at least one marker gene, wherein said marker gene comprises Siglec 1. (62) Divided Out of 526924
Patent NZ-544607-A (NZ)
Title: Rope terminator usinf interlocking hollow conical wedges to trap and secure the fibers of the rope
Inventor: PEARCE COLIN RICHARD
IPC: F16G11/05
Filed: 2004-06-14
Abstract: A connector assembly (30) for preventing sealing connection with a non-permitted, substantially uniform internal diameter conduit having an end face is disclosed. The connector assembly (30) comprises a first connector (36) having a floor (46) and a coupling portion (42). The coupling portion (42) projects outward from the floor (46), the coupling portion (42) including a sealing surface (48) and a non-sealing surface (52), the non-sealing surface (52) being located closer to a free end (44) of the first connector (36) than the sealing surface (48), the non-sealing surface (52) being sized and shaped to hold the non-permitted conduit off of the sealing surface (48) and prevent sealing therewith though the action of the passages (58). A bleed passage (60) is located generally adjacent the floor (46) for bleeding fluid out of the connector assembly (30).
Patent NZ-546194-A (NZ)
Title: A fence support
Inventor: BOYCE GRANT BRUCE
Filed: 2006-03-27
Abstract: A support 1 for fencing material comprises a base part 2, a support part 3 and a clamping part 4. The support part 3 supports the fencing material and acts in conjunction with the clamping part 4 to hold the fencing material in a desired position. The support allows for adjustment of the position of the fencing material by means of internal packers within the support. The fencing material is preferably a transparent material such as glass.